This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Org. Chem. 2019, 15, 1394–1406, doi:10.3762/bjoc.15.139
Graphical Abstract
Scheme 1: (a) Schematic illustration of IDA. The addition of an analyte competitor leads to switch-on or swit...
Scheme 2: (a) The chemical structure of GC5A and schematic illustration of the binding between the luminescen...
Figure 1: Direct fluorescence titrations (λex = 350 nm) of 2,6-TNS (1.0 μM) (a) and 1,8-ANS (1.0 μM) (c) with...
Figure 2: (a) Direct fluorescence titration (λex = 327 nm) of P-TPE (1.0 μM) with GC5A in HEPES buffer (10 mM...
Figure 3: (a) Direct fluorescence titration (λex = 371 nm) of TPS (1.0 μM) with GC5A in HEPES buffer (10 mM, ...
Figure 4: (a) Direct fluorescence titration (λex = 465 nm) of Ru(dcbpy)3 (1.0 μM) with GC5A. (b) Direct absor...
Beilstein J. Org. Chem. 2018, 14, 1840–1845, doi:10.3762/bjoc.14.157
Scheme 1: The chemical structures of (a) bisphosphonates (BPs) and (b) guanidinium-modified calix[5]arene (GC...
Scheme 2: Schematic illustration of the binding between BPs and GC5A and the operating IDA principle of fluor...
Scheme 3: The chemical structures of the selected BP drugs.
Figure 1: (a) Fluorescence competitive titration of GC5A·Fl (0.9/1.0 μM) with risedronate (up to 29.6 μM) in ...
Figure 2: The set-up calibration lines of the fluorescence intensities for quantitatively determining the con...